A detailed history of Optas, LLC transactions in Amgen Inc stock. As of the latest transaction made, Optas, LLC holds 1,021 shares of AMGN stock, worth $289,565. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,021
Previous 1,008 1.29%
Holding current value
$289,565
Previous $314,000 4.46%
% of portfolio
0.08%
Previous 0.08%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$309.38 - $337.38 $4,021 - $4,385
13 Added 1.29%
1,021 $328,000
Q2 2024

Jul 25, 2024

SELL
$262.75 - $319.31 $18,129 - $22,032
-69 Reduced 6.41%
1,008 $314,000
Q1 2024

Apr 17, 2024

SELL
$268.87 - $324.56 $3,764 - $4,543
-14 Reduced 1.28%
1,077 $306,000
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $42,446 - $47,884
166 Added 17.95%
1,091 $314,000
Q3 2023

Oct 31, 2023

BUY
$218.65 - $271.46 $202,251 - $251,100
925 New
925 $248,000
Q4 2022

Jan 27, 2023

BUY
$229.03 - $291.01 $181,162 - $230,188
791 New
791 $207,000
Q4 2020

Jan 27, 2021

SELL
$216.38 - $257.67 $267,445 - $318,480
-1,236 Closed
0 $0
Q3 2020

Oct 23, 2020

BUY
$234.65 - $260.95 $290,027 - $322,534
1,236 New
1,236 $314,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Optas, LLC Portfolio

Follow Optas, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.